- Title
- Baseline Characteristics of Patients with Refractory Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Enrolled in a Phase III, Randomized, Placebo-Controlled Trial of Omalizumab
- Creators
- Karin Rosen (Author)Hsin-Ju Hsieh (Author)Panayiotis Georgiou (Author)Thomas B. Casale (Author) - Creighton UniversityMarcus Maurer (Author)
- Publication Details
- Journal of Allergy and Clinical Immunology, Vol.131(2, Supplement), p.AB29
- Number of pages
- AB29
- Identifiers
- 991005931171902656
- Academic Unit
- School of Medicine; Allergy-Immunology
- Resource Type
- Journal article
Journal article
Baseline Characteristics of Patients with Refractory Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Enrolled in a Phase III, Randomized, Placebo-Controlled Trial of Omalizumab
Journal of Allergy and Clinical Immunology, Vol.131(2, Supplement), p.AB29
2013
Metrics
6 Record Views